Future antibiotics supply needs sustained government support

The article covers key takeaways from the launch of the 2026 AMR Benchmark, highlighting the need for action by both the public and private sectors in order to address the rise of AMR, as well as the importance of balancing access and stewardship of antimicrobial medicines.

Claudia Martínez, Director of Research at the Access to Medicine Foundation is quoted: “The bottom line here… is that we really need more incentives to come to the fore.”

While emphasising the importance of governments continuing to incentivise companies to do more on AMR stewardship, she also notes that companies share the responsibility in mitigating AMR.

The article also highlights the importance of creating access to a broad range of antimicrobial products globally, in order to reduce misuse of drugs in absence of appropriate treatments – a key contributor to drug-resistance.

Claudia Duarte, Research Coordinator within the Foundation’s AMR Programme is quoted: “Oftentimes with antimicrobial resistance, we think so much about the overuse that it’s difficult to think of access as fuelling that.”